Cargando…

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia

Leukocyte immunoglobulin (Ig)-like receptor Bs (LILRBs), a family of type I transmembrane glycoproteins, are known to inhibit immune activation. Here, we comprehensively evaluated the molecular, prognostic, and immunological characteristics of LILRB members in a broad spectrum of cancer types, focus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zi-jun, Zhang, Xin-long, Jin, Ye, Wang, Shi-sen, Gu, Yu, Ma, Ji-chun, Wen, Xiang-mei, Leng, Jia-yan, Mao, Zhen-wei, Lin, Jiang, Qian, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233190/ https://www.ncbi.nlm.nih.gov/pubmed/35795094 http://dx.doi.org/10.1016/j.omto.2022.05.011

Ejemplares similares

LILRB4, an immune checkpoint on myeloid cells
por: Yang, Ting, et al.
Publicado: (2022)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
por: Zhang, Ling‐yi, et al.
Publicado: (2021)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
por: Wen, Xiang-mei, et al.
Publicado: (2021)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
por: Zeller, Tobias, et al.
Publicado: (2023)

Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans
por: Bashirova, Arman A., et al.
Publicado: (2022)

The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis
por: Bylińska, Aleksandra, et al.
Publicado: (2017)

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration
por: Deng, Mi, et al.
Publicado: (2018)

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia
por: Xu, Zi‐jun, et al.
Publicado: (2022)

Molecular regulatory mechanism of LILRB4 in the immune response
por: LIU, Haiyin, et al.
Publicado: (2023)

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia
por: Lin, Mei-si, et al.
Publicado: (2022)

Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
por: Wang, Qihui, et al.
Publicado: (2019)

LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence
por: Ryu, Myongchol, et al.
Publicado: (2011)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
por: Li, Dan-Pei, et al.
Publicado: (2023)

Checkpoint Inhibitors in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2023)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021)

LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis
por: Singh, Vipul K., et al.
Publicado: (2022)

Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
por: de Moraes, Amarilis Giaretta, et al.
Publicado: (2022)

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
por: Dinardo, Courtney, et al.
Publicado: (2023)

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2019)

LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis
por: Wu, Guojin, et al.
Publicado: (2021)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
por: Harrison, Thomas E., et al.
Publicado: (2020)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Liao, Dan, et al.
Publicado: (2019)

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
por: Lee, Ha-Na, et al.
Publicado: (2022)

Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
por: Sim, Janet, et al.
Publicado: (2019)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
por: Hu, Xuelian, et al.
Publicado: (2020)

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
por: Jian, Jimo, et al.
Publicado: (2023)

Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
por: Giannopoulos, Krzysztof
Publicado: (2019)

Expression patterns of immune checkpoints in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2020)

KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure
por: Nowak, Izabela, et al.
Publicado: (2017)

Structural basis of malaria RIFIN binding by LILRB1-containing antibodies
por: Chen, Yiwei, et al.
Publicado: (2021)

281 Fc gamma receptor crosslinking promotes antibody-induced LILRB4 internalization and immune regulation of acute monocytic leukemia
por: Morse, Joshua, et al.
Publicado: (2023)

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
por: Lin, Chien-Chin, et al.
Publicado: (2017)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022)

Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis
por: Ren, Yajun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j70raalheujg2i06s19r8sqarl